Global PTABalloon Catheter Market, by Material Type (Polyurethane, Nylon, andOthers), by Application (Coronary Artery Disease and Peripheral VascularDisease), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, andOthers), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa), was valued at US$ 1,127.7 million in 2017, and isprojected to exhibit a CAGR of 6.8% over the forecast period (2019 – 2026), ashighlighted in a new report published by.
Increasing prevalence ofurological and cardiovascular diseases is expected to augment the PTA ballooncatheter market growth Increasing number of cardiovascular diseases andurological diseases fuels the global PTA balloon catheter market growth.Increase in number of regulatory approvals, product launches and mergers andacquisitions are expected to augment the growth in the global PTA ballooncatheter market. For instance, in November 2015, SurModics, Inc. (Nasdaq: SRDX), a leadingprovider of medical device and in vitrodiagnostic technologies, today announcedit has acquired Creagh Medical Ltd., an innovative developer and manufacturerof percutaneous transluminal angioplasty (PTA) balloon catheters. Theacquisition is a major step forward in SurModics’ strategy to transform itsMedical Device business from being a provider of coating technologies, tooffering whole-product solutions to medical device customers in the large andgrowing global interventional vascular market. Increasing number of product launches and approvals is also expected tofuel the global PTA balloon catheter market growth. For instance, in December2016, BrosMed announced the U.S FDA 510(k) clearance and launch of its HermesNC 0.035 OTW PTA, Achilles NC 0.018 OTW PTA, and Castor NC 0.014 OTW PTAballoon dilatation catheter for the treatment of patients with peripheralarterial diseases.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2815
Furthermore, in April 2019,Becton, Dickinson and Company announced the launch of UltraScore 014 focusedforce percutaneous transluminal angioplasty (PTA) balloon. The UltraScoreballoon is intended to dilate stenoses in the iliac, femoral, ilio-femoral,popliteal, infra-popliteal and renal arteries and for the treatment ofobstructive lesions of native or synthetic arteriovenous dialysisfistulae. The FDA has identified someclass 1 recalls which are most serious types of recalls. By using these devicesmay cause the serious injuries or death. For instance, on May 2019, CookMedical recalled the Advance Enforcer 35 Focal Force PTA balloon catheter dueto the balloon bursting below the rated burst pressure.
Browse 32 Market Data Tables and20 Figures spread through 178 Pages and in-depth TOC on “PTA Balloon CatheterMarket”- Global Forecast to 2026, by Material Type (Polyurethane, Nylon, andOthers), by Application (Coronary Artery Disease and Peripheral VascularDisease), by End User (Hospitals or Clinics, Ambulatory Surgical Centers, andOthers), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa)
High potency PTA balloon catheterare considered as a growth opportunity for manufacturers and Increasing demandfor angioplasty surgery is expected to propel the PTA balloon catheter marketgrowth. Moreover, in December 2017, iVascular announced the release of newOceanus 14 Pro PTA balloon catheter, which received CE mark approval to dilatestenoses in femoral, popliteal, and infrapopliteal arteries, and for the treatmentof obstructive lesions in arteriovenous dialysis fistulae.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/pta-balloon-catheter-market-2815
Key Takeaways of the PTA ballooncatheter Market:
The global PTA balloon cathetermarket is expected to exhibit a CAGR of 6.8% over the forecast period, owing toincreasing demand for high potency PTA balloon catheters, rising demand foroffering PTA balloon catheter manufacturing, and increasing prevalence ofcardiovascular disease.
Among application, peripheralvascular disease segment held dominant position in the PTA balloon cathetermarket in 2018, owing to broad range of peripheral vascular applications. Forinstance, in May 2018, Surmodics Inc., a provider of medical device andin-vitrodiagnostic technologies, received the U.S. Food and Drug Administration(FDA) 510(k) clearance for its .018-inch Low-Profile percutaneous transluminalangioplasty (PTA) balloon dilation catheter, designed and indicated for a broadrange of peripheral vascular applications.
Major players operating in theglobal PTA balloon catheter market include, Medtronic, Terumo, Cardinal Health,Boston Scientific, AndraTec, Cook Medical, Biotronik, Abbott, Creagh Medical,TriReme Medical, and Natec Medical.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2815
About CoherentMarket Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
